The new frontier: gene and oligonucleotide therapy
- 31 January 1994
- journal article
- review article
- Published by Elsevier in Pharmaceutica Acta Helvetiae
- Vol. 68 (3), 145-159
- https://doi.org/10.1016/0031-6865(94)90037-x
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Human Gene Marker/Therapy Clinical ProtocolsHuman Gene Therapy, 1993
- Artificial viral envelopes containing recombinant Human Immunodeficiency Virus (HIV) gp160Life Sciences, 1992
- Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer.The Journal of Experimental Medicine, 1992
- Phosphatodylethanolamine liposomes: drug delivery, gene transfer and immunodiagnostic applicationsBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1992
- Long-Term Improvement of Hypercholesterolemia After Ex Vivo Gene Therapy in LDLR-Deficient RabbitsScience, 1991
- Treatment of Established Renal Cancer by Tumor Cells Engineered to Secrete Interleukin-4Science, 1991
- A novel cationic liposome reagent for efficient transfection of mammalian cellsBiochemical and Biophysical Research Communications, 1991
- Liposomes for the transformation of eukaryotic cellsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1991
- Inhibition of Human Immunodeficiency Virus Type 1-mediated Cytopathic Effects by Poly(L-lysine)-conjugated Synthetic Antisense OligodeoxyribonucleotidesJournal of General Virology, 1989
- Rapid Communication: In vivo Transfection of Murine Lungs with a Functioning Prokaryotic Gene using a Liposome VehicleThe American Journal of the Medical Sciences, 1989